MedTrace Logo

eValuating iDA Selection Ability. The VISA Study.

NCT04969822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1066

Last updated 2024-12-02

Study results available
· View outcomes & findings →

Summary

A non-inferiority, prospective parallel group, multi-center, randomized controlled trial to investigate whether selection of a single blastocyst for transfer using the deep learning tool, iDA, results in non-inferior clinical pregnancy rate compared to trained embryologists using standard morphology criteria.

Conditions

Interventions

DEVICE

iDAScore®

A system that studies time lapse images obtained from the embryo culture system, Embryoscope, throughout the development to blastocyst. The system uses data acquired from a sequence of embryo images and has taught itself to identify the embryos with the highest likelihood of implanting and leading to fetal heart-beat detection.

Sponsors & Collaborators

  • Vitrolife

    lead INDUSTRY

Principal Investigators

  • Peter Illingworth, A/Prof · Virtus Health, Sydney, Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-20
Primary Completion
2023-01-24
Completion
2023-11-01

Countries

  • Australia
  • Denmark
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04969822 on ClinicalTrials.gov